Skip to content
Exosome consulting
  • Home
  • About us
  • ServicesExpand
    • For indusry
    • For academia
    • For investors
  • News
  • Career
  • Contact
Exosome consulting

News

Home / News
  • Our March – April update
    The State of the Vesicle

    Our March – April update

    Read More Our March – April updateContinue

  • Our February update
    The State of the Vesicle

    Our February update

    Read More Our February updateContinue

  • Our January update
    The State of the Vesicle

    Our January update

    Read More Our January updateContinue

  • FDA Modernization Act 2.0 and development of exosome-based therapies
    White paper

    FDA Modernization Act 2.0 and development of exosome-based therapies

    Read our analysis on how changes to the Section 505 of the Federal Food, Drug, and Cosmetic Act introduced by the FDA Modernization…

    Read More FDA Modernization Act 2.0 and development of exosome-based therapiesContinue

  • Introducing KnowlEx™ Cloud
    White paper

    Introducing KnowlEx™ Cloud

    Are you ready to take a peek behind the curtain of Exosome Consulting and see how we help our clients make the right…

    Read More Introducing KnowlEx™ CloudContinue

  • Exosome-based diagnostics and therapeutics markets
    White paper

    Exosome-based diagnostics and therapeutics markets

    Our new INSIGHTS paper, “Investing into extracellular vesicle-based diagnostic and therapeutics. Uncovering the opportunities, challenges, and restraints in the emerging markets.” is live….

    Read More Exosome-based diagnostics and therapeutics marketsContinue

Contact

Exosome Consulting UG (haftungsbeschränkt)
Henkestraße 91,
91052 Erlangen
Germany.

[email protected]

Impressum © 2026 Exosome consulting

  • Home
  • About us
  • Services
    • For indusry
    • For academia
    • For investors
  • News
  • Career
  • Contact